MRI in Pregnancy and Precision Medicine : A Review from Literature
Magnetic resonance imaging (MRI) offers excellent spatial and contrast resolution for evaluating a wide variety of pathologies, without exposing patients to ionizing radiations. Additionally, MRI offers reproducible diagnostic imaging results that are not operator-dependent, a major advantage over ultrasound. MRI is commonly used in pregnant women to evaluate, most frequently, acute abdominal and pelvic pain or placental abnormalities, as well as neurological or fetal abnormalities, infections, or neoplasms. However, to date, our knowledge about MRI safety during pregnancy, especially about the administration of gadolinium-based contrast agents, which are able to cross the placental barrier, is still limited, raising concerns about possible negative effects on both the mother and the health of the fetus. Contrast agents that are unable to cross the placenta in a way that is safe for the fetus are desirable. In recent years, some preclinical studies, carried out in rodent models, have evaluated the role of long circulating liposomal nanoparticle-based blood-pool gadolinium contrast agents that do not penetrate the placental barrier due to their size and therefore do not expose the fetus to the contrast agent during pregnancy, preserving it from any hypothetical risks. Hence, we performed a literature review focusing on contrast and non-contrast MRI use during pregnancy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
Journal of personalized medicine - 12(2021), 1 vom: 23. Dez. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Gatta, Gianluca [VerfasserIn] |
---|
Links: |
---|
Themen: |
Gadolinium |
---|
Anmerkungen: |
Date Revised 28.01.2022 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/jpm12010009 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM33589965X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM33589965X | ||
003 | DE-627 | ||
005 | 20231225230915.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/jpm12010009 |2 doi | |
028 | 5 | 2 | |a pubmed24n1119.xml |
035 | |a (DE-627)NLM33589965X | ||
035 | |a (NLM)35055324 | ||
035 | |a (PII)9 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Gatta, Gianluca |e verfasserin |4 aut | |
245 | 1 | 0 | |a MRI in Pregnancy and Precision Medicine |b A Review from Literature |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 28.01.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Magnetic resonance imaging (MRI) offers excellent spatial and contrast resolution for evaluating a wide variety of pathologies, without exposing patients to ionizing radiations. Additionally, MRI offers reproducible diagnostic imaging results that are not operator-dependent, a major advantage over ultrasound. MRI is commonly used in pregnant women to evaluate, most frequently, acute abdominal and pelvic pain or placental abnormalities, as well as neurological or fetal abnormalities, infections, or neoplasms. However, to date, our knowledge about MRI safety during pregnancy, especially about the administration of gadolinium-based contrast agents, which are able to cross the placental barrier, is still limited, raising concerns about possible negative effects on both the mother and the health of the fetus. Contrast agents that are unable to cross the placenta in a way that is safe for the fetus are desirable. In recent years, some preclinical studies, carried out in rodent models, have evaluated the role of long circulating liposomal nanoparticle-based blood-pool gadolinium contrast agents that do not penetrate the placental barrier due to their size and therefore do not expose the fetus to the contrast agent during pregnancy, preserving it from any hypothetical risks. Hence, we performed a literature review focusing on contrast and non-contrast MRI use during pregnancy | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a MRI | |
650 | 4 | |a gadolinium | |
650 | 4 | |a liposomal gadolinium | |
650 | 4 | |a precision medicine | |
650 | 4 | |a pregnancy | |
650 | 4 | |a safety during pregnancy | |
700 | 1 | |a Di Grezia, Graziella |e verfasserin |4 aut | |
700 | 1 | |a Cuccurullo, Vincenzo |e verfasserin |4 aut | |
700 | 1 | |a Sardu, Celestino |e verfasserin |4 aut | |
700 | 1 | |a Iovino, Francesco |e verfasserin |4 aut | |
700 | 1 | |a Comune, Rosita |e verfasserin |4 aut | |
700 | 1 | |a Ruggiero, Angelo |e verfasserin |4 aut | |
700 | 1 | |a Chirico, Marilena |e verfasserin |4 aut | |
700 | 1 | |a La Forgia, Daniele |e verfasserin |4 aut | |
700 | 1 | |a Fanizzi, Annarita |e verfasserin |4 aut | |
700 | 1 | |a Massafra, Raffaella |e verfasserin |4 aut | |
700 | 1 | |a Belfiore, Maria Paola |e verfasserin |4 aut | |
700 | 1 | |a Falco, Giuseppe |e verfasserin |4 aut | |
700 | 1 | |a Reginelli, Alfonso |e verfasserin |4 aut | |
700 | 1 | |a Brunese, Luca |e verfasserin |4 aut | |
700 | 1 | |a Grassi, Roberto |e verfasserin |4 aut | |
700 | 1 | |a Cappabianca, Salvatore |e verfasserin |4 aut | |
700 | 1 | |a Viola, Luigi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of personalized medicine |d 2011 |g 12(2021), 1 vom: 23. Dez. |w (DE-627)NLM228113881 |x 2075-4426 |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2021 |g number:1 |g day:23 |g month:12 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/jpm12010009 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 12 |j 2021 |e 1 |b 23 |c 12 |